% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Nout:278650,
author = {R. Nout and G. Calaminus and F. Planchamp and C. Chargari
and S. F. Lax and H. Martelli and W. G. McCluggage and P.
Morice and M. Pakiz and M. P. Schmid and J. Stunt and B.
Timmermann$^*$ and C. Vokuhl and D. Orbach and C.
Fotopoulou},
title = {{ESTRO}/{ESGO}/{SIOP}e guidelines for the management of
patients with vaginal cancer.},
journal = {Radiotherapy and oncology},
volume = {186},
issn = {0167-8140},
address = {Amsterdam [u.a.]},
publisher = {Elsevier Science},
reportid = {DKFZ-2023-01694},
pages = {109662},
year = {2023},
abstract = {Primary vaginal malignancies are rare, comprising only
$2\%$ of all female genital tract malignancies in adults and
$4.5\%$ in children. As part of its mission to improve the
quality of care for women with gynecological cancers across
Europe, the European Society of Gynaecological Oncology
(ESGO) jointly with the European Society for Radiotherapy
$\&$ Oncology (ESTRO) and the European Society of Pediatric
Oncology (SIOPe) developed evidence-based guidelines in
order to improve the management of patients with vaginal
cancer within a multidisciplinary setting. ESTRO/ESGO/SIOPe
nominated practicing clinicians who are involved in the
management of vaginal cancer patients and have demonstrated
leadership through their expertise in clinical care and
research, their national and international engagement and
profile as well as dedication to the topics addressed to
serve on the expert panel (13 experts across Europe
comprising the international development group). To ensure
that the statements were evidence based, the current
literature was reviewed and critically appraised. In the
case of absence of any clear scientific evidence, judgment
was based on the professional experience and consensus of
the international development group. Prior to publication,
the guidelines were reviewed by 112 independent
international practitionners in cancer care delivery and
patient representatives and their comments and input were
incorporated and addressed accordingly. These guidelines
cover comprehensively the diagnostic pathways as well as the
surgical, radiotherapeutical and systemic management and
follow-up of adult patients (including those with rare
histological subtypes) and pediatric patients (vaginal
rhabdomyosarcoma and germ cell tumours) with vaginal
tumours.},
keywords = {Adult / Female / Humans / Child / Vaginal Neoplasms:
radiotherapy / Radiation Oncology / Gynecology / Medical
Oncology / Uterine Cervical Neoplasms: therapy / Carcinoma
in Situ / Adolescent (Other) / Adult (Other) / Childhood
(Other) / Guidelines (Other) / Management (Other) / Vaginal
cancer (Other)},
cin = {ED01},
ddc = {610},
cid = {I:(DE-He78)ED01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37244358},
doi = {10.1016/j.radonc.2023.109662},
url = {https://inrepo02.dkfz.de/record/278650},
}